News about Drug Discovery & Development

Johns Hopkins Researchers Develop Cloud-Based Microscope for Continuous Brain Monitoring

Johns Hopkins researchers have developed CloudScope, a cloud-based microscope that enables continuous remote monitoring of brain activity and disease-related changes in freely moving mice for more than 24 hours.

Drug Discovery & Development | 15/09/2026 | By News Bureau

Johns Hopkins Researchers Identify Human Resistin as Key Driver of Inflammatory Pathway

Researchers found that blocking human resistin with a targeted antibody reduced activation of the NLRP3 inflammatory pathway, pointing to a potential target for future therapies.

Drug Discovery & Development | 07/09/2026 | By News Bureau

New Study Reveals Temperature-Induced Structure Recovery Patterns for Drug Delivery

The Raman Research Institute (RRI) researchers study temperature-induced structure recovery in glass, exploring ways to erase material memory and potentially improve drug delivery systems.

Drug Discovery & Development | 02/09/2026 | By News Bureau

New Molecular Method Speeds Drug Discovery by Swapping a Single Atom

Chicago chemists develop a faster and cheaper method to convert isoxazoles into pyrroles, potentially accelerating drug discovery and pharmaceutical development.

Drug Discovery & Development | 02/09/2026 | By News Bureau

Bayer's Finerenone Shows Kidney and Cardiovascular Benefits in Hypertensive CKD Subgroup

New FIND-CKD data highlight finerenone’s potential to slow kidney disease progression and reduce cardiovascular-kidney risks in patients with hypertensive nephropathy.

Drug Discovery & Development | 01/09/2026 | By News Bureau

Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics

Rznomics joins Lilly Gateway Labs in San Diego to accelerate RNA therapeutics development, expand global partnerships and advance its pipeline of 200+ disease targets.

Drug Discovery & Development | 25/08/2026 | By News Bureau

Dale Bredesen Proposes Pr2 Theory as New Framework for Understanding Alzheimer's and Neurodegeneration

Neuroscientist Dale E. Bredesen has proposed the Pr2 theory, a new framework that views neurodegeneration as a response to persistent biological stress and explores a precision-medicine approach to Alzheimer’s disease.

Drug Discovery & Development | 24/08/2026 | By News Bureau

Genprex Partners with US CDMO to Scale Up Diabetes Gene Therapy Manufacturing

Genprex has partnered with a US-based CDMO to scale up cGMP manufacturing of its AAV-based diabetes gene therapy candidate, supporting IND-enabling studies and future clinical trials.

Drug Discovery & Development | 19/08/2026 | By News Bureau

TCS Launches AgentHub to Scale Agentic AI Across Drug Development

TCS has launched ADD AgentHub, an enterprise-ready agentic AI platform designed to transform clinical development and pharmacovigilance while maintaining human oversight, regulatory compliance and auditability.

Drug Discovery & Development | 18/08/2026 | By News Bureau |  143

FDA Clears Graviton BioScience's GV101 for Phase 2 Development in Friedreich's Ataxia

Graviton BioScience has received FDA IND clearance for a new GV101 capsule formulation, paving the way for a Phase 2 trial in patients with Friedreich’s ataxia.

Drug Discovery & Development | 12/08/2026 | By News Bureau |  367